BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20702723)

  • 1. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor.
    Bolitho C; Hahn MA; Baxter RC; Marsh DJ
    Endocr Relat Cancer; 2010 Dec; 17(4):929-40. PubMed ID: 20702723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
    Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
    Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine stimulation of MMP-1(collagenase-1) secretion and gene expression in gastric epithelial cells: role of EGFR transactivation and the MAP kinase pathway.
    Ancha HR; Kurella RR; Stewart CA; Damera G; Ceresa BP; Harty RF
    Int J Biochem Cell Biol; 2007; 39(11):2143-52. PubMed ID: 17656145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer.
    Lee CH; Syu SH; Liu KJ; Chu PY; Yang WC; Lin P; Shieh WY
    Oncotarget; 2015 Nov; 6(36):38866-80. PubMed ID: 26462152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines.
    Moscova M; Marsh DJ; Baxter RC
    Cancer Res; 2006 Feb; 66(3):1376-83. PubMed ID: 16452192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.
    Yin J; Yu FS
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):132-9. PubMed ID: 18658095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta}.
    Mertens-Walker I; Bolitho C; Baxter RC; Marsh DJ
    Endocr Relat Cancer; 2010 Jun; 17(2):335-49. PubMed ID: 20215102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY; Shin SJ; Kim HS
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells.
    Yu Y; Zhang M; Zhang X; Cai Q; Zhu Z; Jiang W; Xu C
    J Exp Clin Cancer Res; 2014 Sep; 33(1):85. PubMed ID: 25261977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
    Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
    Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
    Xu KP; Yin J; Yu FS
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
    Vacca F; Bagnato A; Catt KJ; Tecce R
    Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
    Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
    Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
    Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
    Dong YL; Kabir SM; Lee ES; Son DS
    PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
    Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.
    Reimer D; Hubalek M; Riedle S; Skvortsov S; Erdel M; Concin N; Fiegl H; Müller-Holzner E; Marth C; Illmensee K; Altevogt P; Zeimet AG
    Cancer Res; 2010 Jun; 70(11):4613-23. PubMed ID: 20460525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.
    Huang S; Zhang A; Ding G; Chen R
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1323-33. PubMed ID: 19339632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.